<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font26 { font-size : 26; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">RSV </span>
   <span class="font26">respiratory </span>
   <span class="font26">virus </span>
   <span class="font24">ALRI </span>
   <span class="font23">children </span>
   <span class="font21">RSV-A </span>
   <span class="font21">cases </span>
   <span class="font21">viruses </span>
   <span class="font19">(.; </span>
   <span class="font19">number </span>
   <span class="font18">months </span>
   <span class="font18">syncytial </span>
   <span class="font18">(.%) </span>
   <span class="font18">associated </span>
   <span class="font18">population </span>
   <span class="font17">RSV-B </span>
   <span class="font17">detection </span>
   <span class="font17">incidence </span>
   <span class="font17">specimens </span>
   <span class="font17">{border-style </span>
   <span class="font17">data </span>
   <span class="font17">viral </span>
   <span class="font17">px;} </span>
   <span class="font17">study </span>
   <span class="font17">year </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">detected </span>
   <span class="font16">.–.) </span>
   <span class="font16">selected </span>
   <span class="font16">surveillance </span>
   <span class="font16">using </span>
   <span class="font15">Gambian </span>
   <span class="font15">expected </span>
   <span class="font15">patients </span>
   <span class="font15">used </span>
   <span class="font15">STGG </span>
   <span class="font15">Supplementary </span>
   <span class="font15">Infect. </span>
   <span class="font15">aged </span>
   <span class="font15">analysis </span>
   <span class="font15">estimated </span>
   <span class="font14">(Supplementary </span>
   <span class="font14">PIV- </span>
   <span class="font14">Table </span>
   <span class="font14">acid </span>
   <span class="font14">acute </span>
   <span class="font14">clinical </span>
   <span class="font14">disease </span>
   <span class="font14">pneumonia </span>
   <span class="font14">sequences </span>
   <span class="font14">swabs </span>
   <span class="font14">vaccine </span>
   <span class="font14">G-protein </span>
   <span class="font14">Gambia </span>
   <span class="font14">PIV </span>
   <span class="font14">amino </span>
   <span class="font14">gene </span>
   <span class="font14">month </span>
   <span class="font14">vaccination </span>
   <span class="font13">compared </span>
   <span class="font13">observed </span>
   <span class="font13">positive </span>
   <span class="font13">rural </span>
   <span class="font13">(%) </span>
   <span class="font13">February </span>
   <span class="font13">RSV, </span>
   <span class="font13">[], </span>
   <span class="font13">influenza </span>
   <span class="font13">lower </span>
   <span class="font13">similar </span>
   <span class="font13">sites </span>
   <span class="font13">(.) </span>
   <span class="font13">Health </span>
   <span class="font13">S). </span>
   <span class="font13">age </span>
   <span class="font13">infection </span>
   <span class="font13">infections </span>
   <span class="font13">na) </span>
   <span class="font13">px; </span>
   <span class="font13">vaccines </span>
   <span class="font13">{font-family </span>
   <span class="font12">&amp;lt; </span>
   <span class="font12">December </span>
   <span class="font12">Surveillance </span>
   <span class="font12">antigenic </span>
   <span class="font12">font-size </span>
   <span class="font12">higher </span>
   <span class="font12">introduction </span>
   <span class="font12">manuscript; </span>
   <span class="font12">pneumococcal </span>
   <span class="font12">potential </span>
   <span class="font12">prevalence </span>
   <span class="font12">randomly </span>
   <span class="font12">resident </span>
   <span class="font12">strains </span>
   <span class="font12">studies </span>
   <span class="font12">(Table </span>
   <span class="font12">BHDSS </span>
   <span class="font12">Fig. </span>
   <span class="font12">IV, </span>
   <span class="font12">Kenyan </span>
   <span class="font12">Material </span>
   <span class="font12">RNA </span>
   <span class="font12">Tropical </span>
   <span class="font12">case </span>
   <span class="font12">clustered </span>
   <span class="font12">conjugate </span>
   <span class="font12">design </span>
   <span class="font12">double; </span>
   <span class="font12">hemagglutinin </span>
   <span class="font12">high </span>
   <span class="font12">human </span>
   <span class="font12">impact </span>
   <span class="font12">interpretation, </span>
   <span class="font12">molecular </span>
   <span class="font12">monthly </span>
   <span class="font12">nasopharyngeal </span>
   <span class="font12">oropharyngeal </span>
   <span class="font12">population-based </span>
   <span class="font12">presented </span>
   <span class="font12">review </span>
   <span class="font12">sampling </span>
   <span class="font12">season </span>
   <span class="font12">site </span>
   <span class="font12">target </span>
   <span class="font11">ALRI. </span>
   <span class="font11">African </span>
   <span class="font11">Age </span>
   <span class="font11">Clinical </span>
   <span class="font11">F-protein </span>
   <span class="font11">However, </span>
   <span class="font11">Infectious </span>
   <span class="font11">Medicine, </span>
   <span class="font11">One.e./journal.pone. </span>
   <span class="font11">West </span>
   <span class="font11">active </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">burden </span>
   <span class="font11">characteristics </span>
   <span class="font11">circulation </span>
   <span class="font11">clade </span>
   <span class="font11">collection </span>
   <span class="font11">confidence </span>
   <span class="font11">controls </span>
   <span class="font11">extracted </span>
   <span class="font11">generated </span>
   <span class="font11">greater </span>
   <span class="font11">included </span>
   <span class="font11">loss </span>
   <span class="font11">severe </span>
   <span class="font11">simulation </span>
   <span class="font11">solid; </span>
   <span class="font11">specimen </span>
   <span class="font11">stored </span>
   <span class="font11">subgroup </span>
   <span class="font11">tested </span>
   <span class="font11">years </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(.%, </span>
   <span class="font11">(Ct </span>
   <span class="font11">(Fig. </span>
   <span class="font11">(n = ) </span>
   <span class="font11">Africa. </span>
   <span class="font11">Basse </span>
   <span class="font11">Commons </span>
   <span class="font11">Creative </span>
   <span class="font11">GLY. </span>
   <span class="font11">IQR) </span>
   <span class="font11">IV. </span>
   <span class="font11">Incidence </span>
   <span class="font11">International </span>
   <span class="font11">Mean </span>
   <span class="font11">O-glycosylation </span>
   <span class="font11">RT-PCR </span>
   <span class="font11">Senegal </span>
   <span class="font11">assays </span>
   <span class="font11">bold </span>
   <span class="font11">characterised </span>
   <span class="font11">chest </span>
   <span class="font11">circulated </span>
   <span class="font11">collected </span>
   <span class="font11">courier; </span>
   <span class="font11">criteria </span>
   <span class="font11">design, </span>
   <span class="font11">detection, </span>
   <span class="font11">development </span>
   <span class="font11">diagnosis </span>
   <span class="font11">different </span>
   <span class="font11">distribution </span>
   <span class="font11">drafted </span>
   <span class="font11">em; </span>
   <span class="font11">epidemiological </span>
   <span class="font11">features </span>
   <span class="font11">gain </span>
   <span class="font11">global </span>
   <span class="font11">identified </span>
   <span class="font11">indicate </span>
   <span class="font11">late </span>
   <span class="font11">load </span>
   <span class="font11">median; </span>
   <span class="font11">months, </span>
   <span class="font11">observation </span>
   <span class="font11">period </span>
   <span class="font11">pre-fusion </span>
   <span class="font11">pt;} </span>
   <span class="font11">recommendations </span>
   <span class="font11">sequenced </span>
   <span class="font11">showed </span>
   <span class="font11">specific </span>
   <span class="font11">specimens. </span>
   <span class="font11">standard </span>
   <span class="font11">standardized </span>
   <span class="font11">substitutions </span>
   <span class="font11">supported </span>
   <span class="font11">systematic </span>
   <span class="font11">times </span>
   <span class="font11">transport </span>
   <span class="font11">values </span>
   <span class="font11">viral-associated </span>
   <span class="font11">virus-associated </span>
   <span class="font11">young </span>
  </p>
 </body>
</html>
